Back to Search
Start Over
Myasthenia Gravis Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen R&D, Immunovant
- Source :
- M2 Presswire. January 8, 2025
- Publication Year :
- 2025
-
Abstract
- M2 PRESSWIRE-January 8, 2025-: Myasthenia Gravis Market Poised for Significant Growth from 2024 to 2034, Reports DelveInsight | Sanofi, Cartesian Therapeutics, Takeda, UCB Biopharma, Hoffmann-La Roche, Janssen R&D, Immunovant (C)1994-2025 [...]
- Subjects :
- Johnson & Johnson -- Forecasts and trends
Regeneron Pharmaceuticals Inc. -- Forecasts and trends
Sanofi S.A. -- Forecasts and trends
Biological products industry -- Forecasts and trends
BCG vaccines -- Growth -- Forecasts and trends -- Reports
BCG -- Growth -- Forecasts and trends -- Reports
Epidemiology -- Forecasts and trends -- Reports
Myasthenia gravis -- Forecasts and trends -- Reports
Company growth
Market trend/market analysis
Business
Business, international
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Presswire
- Publication Type :
- News
- Accession number :
- edsgcl.822711802